Literature DB >> 2783251

Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes.

K Motoyoshi1, K Yoshida, K Hatake, M Saito, Y Miura, N Yanai, M Yamada, T Kawashima, G G Wong, P A Temple.   

Abstract

Colony-stimulating factor from human urine (CSF-HU) has been purified to a homogeneous protein, and its complementary DNA (cDNA) has been cloned. Recombinant CSF-HU was prepared from a serum-free medium conditioned by Chinese hamster ovary cells transfected with the cDNA and purified by the same method as that for the native protein. Purified CSF-HU stimulated human bone marrow cells to form macrophage colonies. It also stimulated human mature monocytes prepared from peripheral blood of healthy volunteers to produce human active colony-stimulating activity that stimulates human bone marrow cells to form granulocyte and macrophage colonies. This activity was partially neutralized by the addition of both polyclonal antibodies against human granulocyte colony-stimulating factor and against human granulocyte-macrophage CSF, respectively. The stimulation of monocytes by CSF-HU was not inhibited by the addition of polymyxin-B, which is known as a potent inhibitor of endotoxin. On the other hand, CSF-HU did not stimulate monocyte production of interleukin-1 and interferon. These results indicate that recombinant and native CSF-HU stimulates immature cells as well as mature cells in the human monocyte lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783251

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

Review 1.  Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2010-05-10

2.  Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection.

Authors:  T Kuhara; K Uchida; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo.

Authors:  H Yoshioka; S Hama; T Sadatomo; E Taniguchi; K Harada; K Sugiyama; F Kimura; K Motoyoshi; K Kurisu
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

4.  Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages.

Authors:  T Inaba; H Shimano; T Gotoda; K Harada; M Shimada; M Kawamura; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Increased macrophage colony-stimulating factor levels in patients with Graves' disease.

Authors:  Eriko Morishita; Akiko Sekiya; Tomoe Hayashi; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Hidesaku Asakura; Shinji Nakao; Shigeki Ohtake
Journal:  Int J Hematol       Date:  2008-08-27       Impact factor: 2.490

6.  Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin.

Authors:  T Adachi; H Mano; Y Shinohara; T Nakanishi; T Suzuki; K Ino; N Kato; T Okamoto; A Nawa; S Goto
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

Review 7.  Cytokines and bone marrow transplantation.

Authors:  F Takaku
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.

Authors:  S Suzu; N Yanai; M Saito; T Kawashima; T Kasahara; M Saito; F Takaku; K Motoyoshi
Journal:  Jpn J Cancer Res       Date:  1990-01

9.  Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone-marrow-transplanted mice.

Authors:  N Yanai; M Yamada; K Motoyoshi; H Yokota; K Yoshida; M Saito; T Kawashima; M Nishida; Y Miura; M Saito
Journal:  Jpn J Cancer Res       Date:  1990-04

10.  Augmentation of cancer chemotherapy by preinjection of human macrophage colony-stimulating factor in L1210 leukemic cell-inoculated mice.

Authors:  M Douzono; S Suzu; M Yamada; N Yanai; T Kawashima; K Hatake; K Motoyoshi
Journal:  Jpn J Cancer Res       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.